newdrugapprovals.org
J and J Submits Leukemia Drug, Ibrutinib for Approval
IBRUTINIB 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one New Drug Application Submitted to U.S. FDA for Ibrutinib in the Treatment of Two B-Cell …